“showed a trend”

Change in therapeutic strategy in cases of unfavorable results led to 50.0% restoration or symptom control and showed a trend towards favorable outcome ( p = 0.05).

At index evaluation, MTM patients showed a trend toward higher LVEF (35.9 versus 32.0%, P =0.05), lower mean NT‐proBNP (637 versus 1273 pg/mL, P =0.122), and lower LVEDD (59.9 versus 61.5 mm, P =0.71), although these differences did not meet the threshold of significance.

TRPV1 expression was not significantly altered in CM-treated group compared to vehicles-only control group but the CM-treated group showed a trend towards reduction in TRPV1 protein expression when compared to paclitaxel ( p > 0.05). 3.7 Effect of CM extract administration on microglia activation markers Administration of paclitaxel alone or paclitaxel +250 mg/kg CM extract did not change the microglia status in the spinal cord of mice as dem

Notably, immediate post-procedural angiography showed a trend toward superior results in the drug coated balloon group in terms of MLD, DS%, and acute lumen gain ( p < 0.05) (Table S3 and Table 4 ).

Quantitative difference in GCSF-, MCP-1-, TPO- or IL-6-expression showed a trend towards a change in values, however did not reach statistical significance. hCG levels, were significantly decreased in patients with miscarriage compared to those with ongoing pregnancy (151.75 ± 25.29 IU/l vs. 351.27 ± 111.02 IU/l, p < 0.05) However, they were within normal limits and therefore not predictive for pregnancy outcome.

Finally, the Proteobacteria showed a trend of increasing with age: the relative abundance of Proteobacteria in the 100-day-old group was significantly higher than that in the 80-day-old group (P<0.05).

Conversely, the relative contents of sweet amino acids showed a trend of decreasing and then increasing ( p < 0.05).

But the gene set enrichment analysis performed on the summary statistics of the polygenic risk score (PRS) computed with 6.7 million SNPs spread over the whole genome (pathway-based polygenic risk score analysis) derived from the multi-ancestry BD sample identified several genetic pathways containing purinergic receptor genes that showed a trend of association with BD ( P -values close to GWAS significance ( P = 0.05 _8 ).

The secondary outcomes also showed a trend toward benefit, including body mass index (BMI) and waist-to-hip ratio ( p < 0.05).

Compared to the non-MCT treatment (only training, n = 9), the athletes allocated to the MCT group ( n = 9) significantly ( p < 0.05) decreased lower limb fat and showed a trend ( p > 0.05 and < 0.1) to reduce whole-body fat (Naclerio et al. 2021 ).

It was classified and counted after removing low-quality sequences, and indicated that CPPF showed a trend of increasing OTUs at different levels compared with CY group ( p > 0.05).

In this study, only prolonged hospitalisation showed a trend toward association with CPE carriage ( p=.05 ) Antibiotic Resistance Pattern of ESBL-PE and CPE ESBL-PE showed variable antibiotic resistance to gentamicin (19.4%-100 %) and amoxicillin/clavulanic acid (11.1%–100%).

As the salting continued, the pH values of the raw and cooked egg whites showed a trend in which there was a significant decrease (P < 0.05), followed by a basically stable pH during the late stage of salting.

As meta-analysis showed a trend towards reduction of non-fatal MI with BA (OR 0.57; p=0.05) and significantly lower rates of new-onset or worsening of DM with BA (OR 0.68; p=0.02), which is an independent CV risk factor, there are indications that BA possibly holds the potential to improve clinical outcomes in selected patients at high CV risk.

In addition, they showed a trend effect for up-regulation of genes implicated in GABA synthesis: GLS (p = 0.050) and GAD1 (p = 0.050) and significant down-regulation of ABAT (p = 0.030) that plays a role in GABA metabolism.

We also found that ABCC8 rs1799859 was associated with higher [OR = 1.89 (1.03-3.46), p < 0.05] risk of atherosclerotic plaque after controlling for confounding variables, whilst KCNJ11 rs5219 showed a trend towards lower risk [OR = 0.54 (0.29-1.03), p < 0.05].

MRAP2 variants S80F and R125C showed a trend towards decreasing GHSR cell surface expression compared to control (77.1 ± 6.9% and 72.3 ± 11.7% respectively; P = 0.05 and 0.08 respectively; Fig. 8C ).

In addition, the recurrent course showed a trend of being more frequent than acute and chronic in BD vs. non-BD subjects ( p = 0.05).

Kaplan-Meier analysis also showed a trend of improved survival in mice treated with pevonedistat alone and in combination over the control group (p < 0.05) (Figure 6C ).

Interestingly, ASAP was able to discriminate cirrhosis from both early-stage and advanced-stage pre-HCC (Figure 3 A, p < 0.0001 for both comparisons), while GALAD only showed a trend for discriminating cirrhosis from advanced-stage pre-HCC ( p > 0.05) (Figure 3 B).

However, in several stratifications, KRAS mutation showed a trend towards significance (P ≤ 0.05).

Compared to the model group, the LF-EA group showed a decreasing trend in uterine mass ( P > 0.05), while the HF-EA group demonstrated reductions in uterine mass ( P < 0.05), both the LF-EA group and the HF-EA group showed a trend towards reduced uterine index, transverse diameter of the uterine horns, kidney index, and ovary index ( P > 0.05).

Basal A and RBG levels in S (3.0 ± 0.2 g/dl and 2.8 ± 0.9 mg/dl) were similar to those in T (3.2 ± 0.1 g/dl and 3.1 ± 0.3 mg/dl); in both groups A levels did not show variations up to day 7 while RBG showed a trend toward increase ( P < 0.05 in S).

Conditions that showed a trend ( p ≥ 0.05 and p < 0.1) of sustaining breastfeeding were a history of non-obstetric complications, initiation of prenatal care in the second trimester (compared to not having prenatal care), and receiving BMSs and maternal breast milk as food upon leaving the hospital (compared to receiving BMSs only).

The proprioceptive acuity showed a trend of decline to 3.08 ± 2.07° in dorsiflexion and to −2.59 ± 1.94° in plantar flexion ( p > 0.05).